603 related articles for article (PubMed ID: 19177462)
1. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
[TBL] [Abstract][Full Text] [Related]
2. Increased urinary excretion of orosomucoid is a risk predictor of diabetic nephropathy.
Jiang H; Guan G; Zhang R; Liu G; Liu H; Hou X; Cheng J
Nephrology (Carlton); 2009 Apr; 14(3):332-7. PubMed ID: 19143942
[TBL] [Abstract][Full Text] [Related]
3. Proteomic identification of urinary biomarkers of diabetic nephropathy.
Rao PV; Lu X; Standley M; Pattee P; Neelima G; Girisesh G; Dakshinamurthy KV; Roberts CT; Nagalla SR
Diabetes Care; 2007 Mar; 30(3):629-37. PubMed ID: 17327332
[TBL] [Abstract][Full Text] [Related]
4. Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy.
Sharma K; Lee S; Han S; Lee S; Francos B; McCue P; Wassell R; Shaw MA; RamachandraRao SP
Proteomics; 2005 Jul; 5(10):2648-55. PubMed ID: 15984045
[TBL] [Abstract][Full Text] [Related]
5. Proteome analysis of serum from type 2 diabetics with nephropathy.
Kim HJ; Cho EH; Yoo JH; Kim PK; Shin JS; Kim MR; Kim CW
J Proteome Res; 2007 Feb; 6(2):735-43. PubMed ID: 17269729
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic potential of serum protein pattern in Type 2 diabetic nephropathy.
Yang YH; Zhang S; Cui JF; Lu B; Dong XH; Song XY; Liu YK; Zhu XX; Hu RM
Diabet Med; 2007 Dec; 24(12):1386-92. PubMed ID: 18042080
[TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder.
Jain S; Rajput A; Kumar Y; Uppuluri N; Arvind AS; Tatu U
J Assoc Physicians India; 2005 Jun; 53():513-20. PubMed ID: 16121805
[TBL] [Abstract][Full Text] [Related]
8. Effect of high dose thiamine on the levels of urinary protein biomarkers in diabetes mellitus type 2.
Riaz S; Skinner V; Srai SK
J Pharm Biomed Anal; 2011 Mar; 54(4):817-25. PubMed ID: 21130593
[TBL] [Abstract][Full Text] [Related]
9. Urinary activities of cathepsin B, N-acetyl-beta-D-glucosaminidase, and albuminuria in patients with type 2 diabetes mellitus.
Piwowar A; Knapik-Kordecka M; Fus I; Warwas M
Med Sci Monit; 2006 May; 12(5):CR210-4. PubMed ID: 16641878
[TBL] [Abstract][Full Text] [Related]
10. Proteomics and diabetic nephropathy.
Merchant ML; Klein JB
Semin Nephrol; 2007 Nov; 27(6):627-36. PubMed ID: 18061845
[TBL] [Abstract][Full Text] [Related]
11. Proteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes.
Zhang D; Yang H; Kong X; Wang K; Mao X; Yan X; Wang Y; Liu S; Zhang X; Li J; Chen L; Wu J; Wei M; Yang J; Guan Y
Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E287-95. PubMed ID: 20959534
[TBL] [Abstract][Full Text] [Related]
12. [Change and significance of urinary smad3 in type 2 diabetic nephropathy].
Guo KF; Kou JX; Lu JX; Zhang L; Yu HY; Chen HB
Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(14):1067-71. PubMed ID: 23902838
[TBL] [Abstract][Full Text] [Related]
13. Elevation of urinary betaig-h3, transforming growth factor-beta-induced protein in patients with type 2 diabetes and nephropathy.
Ha SW; Kim HJ; Bae JS; Jeong GH; Chung SC; Kim JG; Park SH; Kim YL; Kam S; Kim IS; Kim BW
Diabetes Res Clin Pract; 2004 Aug; 65(2):167-73. PubMed ID: 15223229
[TBL] [Abstract][Full Text] [Related]
14. E-cadherin tissue expression and urinary soluble forms of E-cadherin in patients with bladder transitional cell carcinoma.
Shi B; Laudon V; Yu S; Dong D; Zhu Y; Xu Z
Urol Int; 2008; 81(3):320-4. PubMed ID: 18931551
[TBL] [Abstract][Full Text] [Related]
15. Does bacteriuria interfere with albuminuria measurements of patients with diabetes?
Kramer CK; Camargo J; Ricardo ED; Almeida FK; Canani LH; Gross JL; Azevedo MJ
Nephrol Dial Transplant; 2009 Apr; 24(4):1193-6. PubMed ID: 19015170
[TBL] [Abstract][Full Text] [Related]
16. Urinary concentrations of the soluble adhesion molecule E-cadherin and total protein in patients with bladder cancer.
Protheroe AS; Banks RE; Mzimba M; Porter WH; Southgate J; Singh PN; Bosomworth M; Harnden P; Smith PH; Whelan P; Selby PJ
Br J Cancer; 1999 Apr; 80(1-2):273-8. PubMed ID: 10390008
[TBL] [Abstract][Full Text] [Related]
17. Study of urinary 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA damage in diabetic nephropathy patients.
Xu GW; Yao QH; Weng QF; Su BL; Zhang X; Xiong JH
J Pharm Biomed Anal; 2004 Sep; 36(1):101-4. PubMed ID: 15351053
[TBL] [Abstract][Full Text] [Related]
18. Urinary type IV collagen levels in diabetes mellitus.
Sthaneshwar P; Chan SP
Malays J Pathol; 2010 Jun; 32(1):43-7. PubMed ID: 20614725
[TBL] [Abstract][Full Text] [Related]
19. Urinary pigment epithelium-derived factor as a marker of diabetic nephropathy.
Chen H; Zheng Z; Li R; Lu J; Bao Y; Ying X; Zeng R; Jia W
Am J Nephrol; 2010; 32(1):47-56. PubMed ID: 20523035
[TBL] [Abstract][Full Text] [Related]
20. Urinary concentration of transforming growth factor-beta-inducible gene-h3(beta ig-h3) in patients with Type 2 diabetes mellitus.
Cha DR; Kim IS; Kang YS; Han SY; Han KH; Shin C; Ji YH; Kim NH
Diabet Med; 2005 Jan; 22(1):14-20. PubMed ID: 15606685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]